H.Z. Ke

FDA guidelines and animal models for osteoporosis

David D. Thompson, Hollis A. Simmons, C.M. Pirie et al. · Bone · 1995 · 523 citations

Bone Disease, Bone Health, Fda Guidelines +3

An EP2 receptor-selective prostaglandin E₂agonist induces bone healing

Vishwas Paralkar, Fran Borovečki, H.Z. Ke et al. · Proceedings of the National Academy of Sciences · 2003 · 185 citations · Full text

Prostaglandin E2, Molecular Physiology, Sclerostin +11

Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.

H.Z. Ke, Hollis A. Simmons, C.M. Pirie et al. · Endocrinology · 1995 · 114 citations

Gynecology, Pharmacotherapy, Osteoporosis +17

Interferon-gamma causes loss of bone volume in vivo and fails to ameliorate cyclosporin A-induced osteopenia.

Gary N. Mann, Thomas Jacobs, Farrel J. Buchinsky et al. · Endocrinology · 1994 · 84 citations

Ifn Gamma, Immunology, Bone Repair +19

Crystal structure of cyclophilin A complexed with substrate Ala-Pro suggests a solvent-assisted mechanism of cis-trans isomerization.

H.Z. Ke, Dale Mayrose, Wen Cao · Proceedings of the National Academy of Sciences · 1993 · 81 citations · Full text

Protein Chemistry, Crystal Structure, Protein Assembly +15